[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Shahriar [@SugarKoat](/creator/twitter/SugarKoat) on x 6604 followers Created: 2025-07-23 06:07:54 UTC GLP-1 is old news (Ozempic). GLP-2 proved more superior (Mounjaro). GLP-3 (Reta) will come and take the world by storm in November when Eli Lilly releases the better than expected results and that'll hold everyone over until quad-agonist releases phase X results and finishes up phase X showing tremendous fat loss and lean mass gain. Influencers who have built a career on diet dogmas are becoming obsolete. XXX engagements  **Related Topics** [influencers](/topic/influencers) [mounjaro](/topic/mounjaro) [superior](/topic/superior) [ozempic](/topic/ozempic) [eli lilly](/topic/eli-lilly) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/SugarKoat/status/1947901467970371661)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Shahriar @SugarKoat on x 6604 followers
Created: 2025-07-23 06:07:54 UTC
GLP-1 is old news (Ozempic). GLP-2 proved more superior (Mounjaro). GLP-3 (Reta) will come and take the world by storm in November when Eli Lilly releases the better than expected results and that'll hold everyone over until quad-agonist releases phase X results and finishes up phase X showing tremendous fat loss and lean mass gain.
Influencers who have built a career on diet dogmas are becoming obsolete.
XXX engagements
Related Topics influencers mounjaro superior ozempic eli lilly stocks healthcare